Using an intraperitoneal mouse model of salmonellosis, Maiti and colleagues revealed that two human beta-defensins (HBD1 and HBD2) are efficient in attenuating the disease and the bacterial load (Maiti et al., 2014). The gene discussed is DEFB1; the disease is salmonellosis.